Quality of Life in Patients With Inoperable Malignant Bowel Obstruction

Inclusion Criteria: * Subjects must demonstrate willingness to participate in the study and to be compliant with any protocol procedure. * Provision of written informed consent prior to any study related procedure. * Diagnosis of an inoperable malignant bowel obstruction, confirmed by appropriate imaging report. * In case of peritoneal carcinomatosis, diagnostic confirmation by CT or MRI scan. * Confirmed as inoperable after medical advice. * Patient with a nasogastric tube or presenting with 3 or more episodes of vomiting every day in the last consecutive 48 hours. * Patient life expectancy must be more than 14 days. Exclusion Criteria: * Has operable obstruction or any sub-obstruction. * Has bowel obstruction due to a non-malignant cause; (hypokaliaemia, drug side-effects, renal insufficiency, etc). * Has signs of bowel perforation. * Has prior treatment with somatostatin or any analogue within the previous 60 days. * Has a known hypersensitivity to any of the study treatments or related compounds. * Is likely to require treatment during the study with somatostatin or any analogue other than the study treatment. * Is at risk of pregnancy or lactation, or is likely to father a child during the study. Females of childbearing potential must provide a negative pregnancy test at start of study and must be using oral or double barrier contraception. Non childbearing potential is defined as post-menopause for at least 1 year, surgical sterilisation or hysterectomy at least thre…